Equities
Swiss Market Index holds gains as UBS leads SMI; 8 of 20 SMI stocks advance
The Swiss SMI closed slightly above 14,000 points after UBS led gains, while regulatory uncertainty over its capital requirements weighed on the index.
B&M European Value Retail Taps Ex-Tesco CFO Mike Iddon as Director
The value retailer has appointed Mike Iddon as an independent non-executive director, effective Jan. 4, 2027, adding a veteran of Tesco, New Look and Pets at Home to its board.
Triple Point Venture VCT announces 2p interim dividend
Triple Point Venture VCT Plc declared a 2 p per share interim dividend for its Venture Share Class shareholders, with payment expected around 16 December 2026.
Zuckerberg’s Muse speech amid Meta rally, oil prices dip as Iran talks gain momentum
Meta’s AI agent Muse propelled the company’s shares up by over 20% since its September 8 launch, while Brent crude fell below $100 per barrel. U.S.-Iran diplomacy showed signs of progress, and geopolitical tensions in the Middle East persisted.
GM Outlines 2026–2030 Growth Plan at JP Morgan Conference
General Motors expects robust cash flow, truck production and digital revenue expansion, with a $20B digital target by 2030.
Deutsche Bank CFO Highlights Revenue Shift, Wealth Growth Amid Strategy Adjustments
Deutsche Bank’s CFO underscored a 60% revenue shift toward non-investment banking divisions and EUR 60 billion in private banking asset inflows, while outlining capital targets and commercial real estate risk reductions.
Renalytix shifts year-end to December 31, extends reporting cycle
Precision medicine firm aligns financial reporting with operational goals, partners with Quest Diagnostics for kidney diagnostics platform
Solid Biosciences Eyes FDA Approval for Gene Therapy in Duchenne, Friedreich’s Ataxia
The biotech firm outlines clinical progress, regulatory milestones and platform expansion ahead of key FDA discussions in late 2026 and 2027.
AGF Management Sees Alternatives Drive Growth Amid CAD 75B AUM Expansion
CEO Judy Goldring highlights EBITDA leverage, AI adoption, and a focus on alternatives to bolster returns amid stable dividend policy.
U.S. Stock Futures Flat Ahead of Trump–Xi Summit as Iran Talks Lift Risk Sentiment
Wall Street futures held steady Tuesday night as investors weighed declining oil prices after U.S.–Iran meetings and tech strength driven by Meta's Muse AI agent, with eyes on Thursday's Washington summit.
FTSE 100 rises as U.S.-Iran diplomacy eases oil-price pressures
U.S. and Iranian envoys held a three-hour meeting in New York, lifting European stocks and pushing Brent crude below $99 a barrel.
Ampeak Energy appoints David Taaffe as CEO
Ampeak Energy announced David Taaffe will serve as its next chief executive officer.
Chip stocks rally in September: Arm, Intel, AMD among leaders
Arm, Intel, AMD and Marvell posted sharp September gains driven by strong data-center demand and AI supply deals, as ProPicks AI models flagged the names for continued outperformance.
Pacific Assets Trust Shares Suspended From London Trading
The London Stock Exchange has halted trading in Pacific Assets Trust while the suspension is in effect.
Airtel Money Plans London IPO Through Secondary Share Sale
The mobile money service is moving toward a London listing via a secondary share sale, according to company announcements.
TotalEnergies approves Ima gas field development in Nigeria
TotalEnergies has approved development of the Ima gas field in Nigeria.
Burger King Spain founder eyes bid to regain control of company
A report says the founder of Burger King Spain is reportedly planning a bid to take back control of the chain.
Pearson names three new non-executive directors for October board intake
Pearson appointed independent directors Michael Barkin and Vivek Sharma plus Cevian Capital partner Alex Svensson to its board effective Oct. 1, 2026.
Nexus Infrastructure Reports £70m Revenue, CEO to Step Down
UK infrastructure firm posts £70m in revenue as it announces an upcoming chief executive departure.
Aurrigo reports 19% revenue growth in first half of 2026
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.
DAX Gains as Iran-U.S. Talks Ease Oil Price Concerns
Germany's benchmark index opened higher Thursday as falling Brent crude and record Nasdaq gains offset political uncertainty at home.
Judges Scientific CFO Brad Ormsby to leave in September 2027
Chief Financial Officer Brad Ormsby will step down on Sept 23, 2027 after a 12‑month notice, ending an 11‑year tenure at the scientific‑instrument group.
Lexicon Pharmaceuticals CEO Highlights Focus on Obesity and Cardiomyopathy Programs
Lexicon Pharmaceuticals reported share declines amid strategic emphasis on obesity and heart disease programs, including a $45M upfront deal with Novo Nordisk for its ACSL5 inhibitor.
Braveheart Bio Outlines Dual HCM Pipeline at Cantor Conference
CEO Travis Murdock highlights Phase II results for BHB-1893 in obstructive and non-obstructive hypertrophic cardiomyopathy, with Phase III trials and regulatory timelines in focus.